Literature DB >> 9779760

Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome.

R Dagan1, E Leibovitz, D Greenberg, P Yagupsky, D M Fliss, A Leiberman.   

Abstract

OBJECTIVE: To determine the relation between early bacteriologic eradication and clinical outcome of acute otitis media (AOM) in infants and young children treated with various antibiotics. STUDY
DESIGN: The study group consisted of patients ages 3 to 24 months seen at the Pediatric Emergency Room with: (1) symptoms and physical findings consistent with AOM of < or = 7 days duration; (2) no spontaneous perforation or tympanostomy tubes; (3) positive initial middle ear fluid culture; and (4) a follow-up to at least Day 10+/-2 of the study with a second culture performed 72 to 96 h after initiation of antibiotic treatment. Any patient with a positive middle ear fluid culture 72 to 96 h after initiation of antibiotic treatment was considered to have bacteriologic failure. Otologic evaluation was done by an otolaryngologist unaware of the culture results and of the study drug allocation. A clinical score based on body temperature, report of irritability and ear tugging observed by the parents and the appearance and redness of the ear drum as observed by the otolaryngologist was also used for clinical evaluation.
RESULTS: The study group consisted of 123 patients, of whom 57 (46%) had positive middle ear fluid 72 to 96 h after initiation of antibiotic treatment. Clinical failure was observed in 21 of 57 (37%) patients in whom bacteriologic eradication did not occur vs. only 2 of 66 (3%) patients with bacteriologic eradication after 3 to 4 days of treatment (P < 0.001). Clinical score for both moderate and severe disease decreased significantly faster in those with bacteriologic eradication than in those in whom middle ear fluid was still culture-positive 72 to 96 h after initiation of treatment.
CONCLUSION: Clinical failures in our population were associated with inability to eradicate the causative organisms of AOM from the middle ear fluid within 3 to 4 days after initiation of antibiotic therapy. Most patients (including those without bacteriologic eradication) improved after 3 to 4 days of treatment, but patients with sterile middle ear fluid felt better after 3 to 4 days of treatment than patients in whom middle ear fluid was still culture-positive.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9779760     DOI: 10.1097/00006454-199809000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  29 in total

1.  Current Concepts of Therapy for Otitis Media.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

2.  Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media.

Authors:  W Erhardt; M Murphy; C Knirsch
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  Study design questions in treatment of children with acute otitis media.

Authors:  Alejandro Hoberman; Jack L Paradise
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

4.  Interleukin 8 in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication.

Authors:  E Leibovitz; R Dagan; J H Laver; L Piglansky; S Raiz; M R Abboud; D M Fliss; A Leiberman; A Barzilai
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

5.  Efficacy of linezolid in experimental otitis media.

Authors:  S I Pelton; M Figueira; R Albut; D Stalker
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  Characterization and dynamics of middle ear fluid and nasopharyngeal isolates of Streptococcus pneumoniae from 12 children treated with levofloxacin.

Authors:  Todd A Davies; Eugene Leibovitz; Gary J Noel; David F McNeeley; Karen Bush; Ron Dagan
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

Review 7.  Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.

Authors:  Jane Easton; Stuart Noble; Caroline M Perry
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Treatment of otitis media by transtympanic delivery of antibiotics.

Authors:  Rong Yang; Vishakha Sabharwal; Obiajulu S Okonkwo; Nadya Shlykova; Rong Tong; Lily Yun Lin; Weiping Wang; Shutao Guo; John J Rosowski; Stephen I Pelton; Daniel S Kohane
Journal:  Sci Transl Med       Date:  2016-09-14       Impact factor: 17.956

9.  Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults.

Authors:  T M File; H Lode; H Kurz; R Kozak; H Xie; E Berkowitz
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  Systemic inflammatory responses in children with acute otitis media due to Streptococcus pneumoniae and the impact of treatment with clarithromycin.

Authors:  Gunter Scharer; Frank Zaldivar; Guillermo Gonzalez; Ofelia Vargas-Shiraishi; Jasjit Singh; Antonio Arrieta
Journal:  Clin Diagn Lab Immunol       Date:  2003-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.